Dual RNA-Seq Enables Full-Genome Assembly of Measles Virus and Characterization of Host-Pathogen Interactions.
dual RNA-seq
genome assembly
host response
measles virus
transcriptome
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
20 Jul 2021
20 Jul 2021
Historique:
received:
21
06
2021
revised:
12
07
2021
accepted:
14
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
Measles virus (MeV) has a negative-sense 15 kb long RNA genome, which is generally conserved. Recent advances in high-throughput sequencing (HTS) and Dual RNA-seq allow the analysis of viral RNA genomes and the discovery of viral infection biomarkers, via the simultaneous characterization of the host transcriptome. However, these host-pathogen interactions remain largely unexplored in MeV infections. We performed untargeted Dual RNA-seq in 6 pharyngeal and 6 peripheral blood mononuclear cell (PBMCs) specimens from patients with MeV infection, as confirmed via routine real-time PCR testing. Following optimised DNase treatment of total nucleic acids, we used the pharyngeal samples to build poly-A-enriched NGS libraries. We reconstructed the viral genomes using the pharyngeal datasets and we further conducted differential expression, gene-ontology and pathways enrichment analysis to compare both the pharyngeal and the peripheral blood transcriptomes of the MeV-infected patients vs. control groups of healthy individuals. We obtained 6 MeV genotype-B3 full-genome sequences. We minutely analyzed the transcriptome of the MeV-infected pharyngeal epithelium, detecting all known viral infection biomarkers, but also revealing a functional cluster of local antiviral and inflammatory immune responses, which differ substantially from those observed in the PBMCs transcriptome. The application of Dual RNA-seq technologies in MeV-infected patients can potentially provide valuable information on the virus genome structure and the cellular innate immune responses and drive the discovery of new targets for antiviral therapy.
Identifiants
pubmed: 34361973
pii: microorganisms9071538
doi: 10.3390/microorganisms9071538
pmc: PMC8303570
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Stavros Niarchos Foundation
ID : "This work was made possible through the grant from the Stavros Niarchos Foundation to the Hellenic Pasteur Institute, as part of the Foundation's initiative to support the Greek research center ecosystem"
Références
Viruses. 2016 Oct 12;8(10):
pubmed: 27754341
Bioessays. 2016 Jul;38(7):627-43
pubmed: 27231150
MMWR Morb Mortal Wkly Rep. 2005 Nov 4;54(43):1100-4
pubmed: 16267497
Science. 2019 Nov 1;366(6465):599-606
pubmed: 31672891
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Neurovirol. 2008 Nov;14(6):486-91
pubmed: 19016379
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nat Struct Mol Biol. 2011 Apr;18(4):471-7
pubmed: 21378962
Curr Opin Virol. 2011 Dec;1(6):519-25
pubmed: 22328912
J Virol. 2011 Sep;85(17):9060-8
pubmed: 21734050
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12792-7
pubmed: 23858444
Innate Immun. 2016 Apr;22(3):181-5
pubmed: 26939595
Viruses. 2016 Apr 21;8(4):112
pubmed: 27110811
PLoS One. 2012;7(4):e35537
pubmed: 22536402
Anticancer Agents Med Chem. 2012 Jul;12(6):631-9
pubmed: 22263797
Virus Res. 2019 Apr 2;263:145-150
pubmed: 30684519
J Infect Dis. 2016 Feb 15;213(4):592-9
pubmed: 26347574
Virology. 2008 Jun 5;375(2):321-30
pubmed: 18374960
Lancet. 2009 Jan 31;373(9661):383-9
pubmed: 19131097
Cancer Manag Res. 2019 Aug 19;11:7813-7824
pubmed: 31695486
Blood. 2011 Apr 14;117(15):e151-60
pubmed: 21325597
Cell Host Microbe. 2011 Dec 15;10(6):534-9
pubmed: 22177558
Clin Infect Dis. 2017 Jul 15;65(2):191-193
pubmed: 28407096
Tumour Biol. 2016 Apr;37(4):4785-9
pubmed: 26518771
FEMS Microbiol Lett. 2009 Jan;290(2):121-8
pubmed: 19025564
Lancet. 2004 Feb 21;363(9409):600-7
pubmed: 14987884
Nature. 2012 Mar 14;483(7390):428-33
pubmed: 22419161
Am J Dis Child. 1962 Mar;103:266-73
pubmed: 14492681
J Infect Dis. 2018 Mar 5;217(6):897-905
pubmed: 29281100
Sci Immunol. 2019 Nov 1;4(41):
pubmed: 31672862
AIDS. 2013 Jun 19;27(10):1583-91
pubmed: 24047763
Nat Rev Microbiol. 2013 Jul;11(7):455-66
pubmed: 23728212
Hum Pathol. 2007 Aug;38(8):1239-47
pubmed: 17499339
Bioorg Med Chem Lett. 2012 Jan 15;22(2):1219-23
pubmed: 22189141
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
PLoS Pathog. 2019 Feb 15;15(2):e1007605
pubmed: 30768648
Arq Bras Endocrinol Metabol. 2013 Dec;57(9):667-76
pubmed: 24402011
J Allergy Clin Immunol. 2014 Mar;133(3):670-8.e12
pubmed: 24495433
Clin Vaccine Immunol. 2007 Jul;14(7):918-23
pubmed: 17538120
J Biol Chem. 2016 Jun 10;291(24):12627-12640
pubmed: 27044744
PLoS Pathog. 2014 Apr 17;10(4):e1004081
pubmed: 24743923
J Immunol. 2008 Nov 15;181(10):7356-66
pubmed: 18981159
Sci Immunol. 2019 Nov 1;4(41):
pubmed: 31672863
Curr Opin Virol. 2012 Jun;2(3):248-55
pubmed: 22483507
Wkly Epidemiol Rec. 2015 Jul 24;90(30):373-80
pubmed: 26211016
J Infect. 2008 Nov;57(5):374-84
pubmed: 18838171
Mol Cell Biol. 2000 May;20(9):3086-96
pubmed: 10757793
J Virol. 2010 Aug;84(16):8332-41
pubmed: 20534863
Mol Cell. 2018 Jul 5;71(1):117-128.e3
pubmed: 30008317
Nat Commun. 2017 Jun 23;8:15720
pubmed: 28643783
Nat Cell Biol. 2002 Mar;4(3):198-207
pubmed: 11836525
Clin Transl Sci. 2016 Dec;9(6):293-301
pubmed: 27766744
Front Microbiol. 2015 Apr 09;6:235
pubmed: 25914674
Cell Rep. 2015 Dec 22;13(11):2425-2439
pubmed: 26673326
Curr Opin Cell Biol. 2007 Dec;19(6):658-62
pubmed: 18023996
J Virol. 2012 Apr;86(7):3411-21
pubmed: 22301134
Nat Rev Dis Primers. 2016 Jul 14;2:16049
pubmed: 27411684
Nat Rev Microbiol. 2012 Sep;10(9):618-30
pubmed: 22890146
Exp Cell Res. 2011 Mar 10;317(5):620-31
pubmed: 21376175
Genome Biol. 2015 Jan 24;16:13
pubmed: 25651527
Cell Rep. 2015 May 26;11(8):1193-207
pubmed: 25981042
Arch Gynecol Obstet. 2014 Apr;289(4):893-901
pubmed: 24213015
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Clin Microbiol. 2017 Feb;55(2):360-368
pubmed: 27795332
PLoS Pathog. 2012;8(8):e1002885
pubmed: 22952446
Cell Cycle. 2016;15(7):974-85
pubmed: 26919204
J Immunol. 2017 Sep 1;199(5):1660-1671
pubmed: 28739876
Nat Commun. 2018 Nov 23;9(1):4944
pubmed: 30470742
J Virol. 2011 Dec;85(24):13019-26
pubmed: 21994456
Genome Biol. 2017 Jan 19;18(1):12
pubmed: 28103897
Front Immunol. 2018 Feb 15;9:227
pubmed: 29497419
Genome Announc. 2018 Mar 29;6(13):
pubmed: 29599155
J Infect Dis. 2011 Jul;204 Suppl 1:S325-34
pubmed: 21666181
PLoS One. 2015 Nov 16;10(11):e0143081
pubmed: 26569100
J Interferon Cytokine Res. 2009 Apr;29(4):199-207
pubmed: 19203244
Trends Microbiol. 2012 Sep;20(9):429-39
pubmed: 22721863
Nature. 2011 Nov 02;480(7378):530-3
pubmed: 22048310
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3363-8
pubmed: 16492729
Biosci Rep. 2010 Mar 17;30(4):243-55
pubmed: 20337599
Onco Targets Ther. 2020 Apr 20;13:3303-3318
pubmed: 32368089
J Infect Dis. 2015 Jul 15;212(2):213-22
pubmed: 25637350
Sci Transl Med. 2016 Jan 20;8(322):322ra11
pubmed: 26791949